Prognostic inflammatory–immune score-based risk stratification optimizes adjuvant therapy for non-gastric gastrointestinal stromal tumors: a multicenter study
BackgroundConventional modified National Institutes of Health (mNIH) and Armed Forces Institute of Pathology (AFIP) systems exhibit “anatomical bias” due to their development from predominantly gastric cohorts, resulting in suboptimal prognostic perfor…